Psycheceutical Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 4

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Psycheceutical General Information

Description

Operator of a biotech firm intended to enhance the safety and efficacy of therapeutic agents for the management of neuropsychiatric and pain conditions. The company's delivery system allows immediate and sustained drug delivery, with safe dosage control and consistent results, while avoiding the gastrointestinal tract and toxicity-related side effects by applying a topical compound at the back of the neck near the hairline, which penetrates peripheral nerve endings along the spinal cord to provide a direct path to neural tissue in the brain, enabling healthcare professionals to deliver psychedelic medicines safely and effectively.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Corporate Office
  • 515 East Las Olas Boulevard
  • Suite 120
  • Fort Lauderdale, FL 33301
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • 515 East Las Olas Boulevard
  • Suite 120
  • Fort Lauderdale, FL 33301
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Psycheceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private Completed Clinical Trials - Phase 1
3. Early Stage VC 01-Jul-2023 Completed Clinical Trials - Phase 1
2. Merger/Acquisition 19-Jan-2022 $405K Completed Stealth
1. Seed Round 12-Oct-2021 $405K $405K Completed Stealth
To view Psycheceutical’s complete valuation and funding history, request access »

Psycheceutical Patents

Psycheceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024159167-A1 Ketamine formulations suitable for topical delivery and related methods Inactive 26-Jan-2023

Psycheceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Psycheceutical Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cantheon Capital PE/Buyout Minority
To view Psycheceutical’s complete investors history, request access »

Psycheceutical FAQs

  • When was Psycheceutical founded?

    Psycheceutical was founded in 2020.

  • Where is Psycheceutical headquartered?

    Psycheceutical is headquartered in Fort Lauderdale, FL.

  • What is the size of Psycheceutical?

    Psycheceutical has 4 total employees.

  • What industry is Psycheceutical in?

    Psycheceutical’s primary industry is Drug Discovery.

  • Is Psycheceutical a private or public company?

    Psycheceutical is a Private company.

  • What is Psycheceutical’s current revenue?

    The current revenue for Psycheceutical is .

  • How much funding has Psycheceutical raised over time?

    Psycheceutical has raised $1.3M.

  • Who are Psycheceutical’s investors?

    Cantheon Capital has invested in Psycheceutical.

  • Who acquired Psycheceutical?

    Psycheceutical was acquired by Psycheceutical Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process